National Health Investors Inc (NYSE:NHI) has earned an average recommendation of “Hold” from the nine ratings firms that are covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a sell rating, three have issued a hold rating and three have issued a buy rating on the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $78.20.
A number of equities analysts recently issued reports on the stock. Zacks Investment Research lowered shares of National Health Investors from a “hold” rating to a “sell” rating in a research report on Tuesday. SunTrust Banks increased their target price on shares of National Health Investors to $85.00 and gave the company a “neutral” rating in a research report on Wednesday, February 20th. They noted that the move was a valuation call. BMO Capital Markets lowered shares of National Health Investors from a “market perform” rating to an “underperform” rating and set a $78.00 target price for the company. in a research report on Wednesday, February 20th. KeyCorp set a $65.00 target price on shares of National Health Investors and gave the company a “sell” rating in a research report on Thursday, December 20th. Finally, ValuEngine upgraded shares of National Health Investors from a “hold” rating to a “buy” rating in a research report on Tuesday, December 11th.
In other National Health Investors news, Director Robert A. Mccabe, Jr. sold 1,181 shares of the company’s stock in a transaction dated Thursday, February 21st. The shares were sold at an average price of $78.04, for a total value of $92,165.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 5.63% of the stock is currently owned by corporate insiders.
A number of hedge funds and other institutional investors have recently modified their holdings of NHI. Russell Investments Group Ltd. lifted its holdings in National Health Investors by 16.3% in the 3rd quarter. Russell Investments Group Ltd. now owns 33,606 shares of the real estate investment trust’s stock valued at $2,540,000 after acquiring an additional 4,710 shares during the last quarter. Wells Fargo & Company MN lifted its stake in National Health Investors by 1.8% during the third quarter. Wells Fargo & Company MN now owns 152,385 shares of the real estate investment trust’s stock valued at $11,519,000 after buying an additional 2,721 shares in the last quarter. Meeder Asset Management Inc. lifted its stake in National Health Investors by 1,298.1% during the third quarter. Meeder Asset Management Inc. now owns 3,020 shares of the real estate investment trust’s stock valued at $228,000 after buying an additional 2,804 shares in the last quarter. Cambridge Investment Research Advisors Inc. lifted its stake in National Health Investors by 23.3% during the third quarter. Cambridge Investment Research Advisors Inc. now owns 7,390 shares of the real estate investment trust’s stock valued at $559,000 after buying an additional 1,395 shares in the last quarter. Finally, HL Financial Services LLC lifted its stake in National Health Investors by 8.3% during the third quarter. HL Financial Services LLC now owns 11,708 shares of the real estate investment trust’s stock valued at $885,000 after buying an additional 900 shares in the last quarter. 70.77% of the stock is owned by institutional investors.
Shares of NHI opened at $79.24 on Friday. The stock has a market capitalization of $3.37 billion, a P/E ratio of 14.46 and a beta of 0.51. The company has a debt-to-equity ratio of 0.92, a current ratio of 17.92 and a quick ratio of 17.92. National Health Investors has a 52-week low of $65.10 and a 52-week high of $84.57.
National Health Investors (NYSE:NHI) last announced its earnings results on Tuesday, February 19th. The real estate investment trust reported $0.87 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.39 by ($0.52). The company had revenue of $74.00 million during the quarter, compared to the consensus estimate of $75.16 million. National Health Investors had a net margin of 52.38% and a return on equity of 11.36%. The business’s quarterly revenue was up 4.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.35 EPS. Equities research analysts expect that National Health Investors will post 5.5 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Friday, March 29th will be issued a $1.05 dividend. This represents a $4.20 dividend on an annualized basis and a yield of 5.30%. This is an increase from National Health Investors’s previous quarterly dividend of $1.00. The ex-dividend date is Thursday, March 28th. National Health Investors’s dividend payout ratio is presently 72.99%.
National Health Investors Company Profile
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
See Also: Fundamental Analysis
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.